Meyka Pro banner
HeartBeam, Inc.

HeartBeam, Inc. Fundamental Analysis (NASDAQ: BEATW)

BEATW●NASDAQ
HealthcareMedical - Specialties
$0.01
$0.008(195.00%)
U.S. Market opens in 15h 6m

HeartBeam, Inc. Fundamental Analysis (NASDAQ: BEATW)

HeartBeam, Inc. (NASDAQ: BEATW) shows weak financial fundamentals with a PE ratio of -0.89, profit margin of 0.00%, and ROE of -4.03%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

Cash Position54.92%
PEG Ratio-0.02
Current Ratio4.64

Areas of Concern

ROE-4.03%
Operating Margin0.00%
We analyze BEATW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -373.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-373.1/100

We analyze BEATW's fundamental strength across five key dimensions:

Efficiency Score

Weak

BEATW struggles to generate sufficient returns from assets.

ROA > 10%
-2.29%

Valuation Score

Excellent

BEATW trades at attractive valuation levels.

PE < 25
-0.89
PEG Ratio < 2
-0.02

Growth Score

Moderate

BEATW shows steady but slowing expansion.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
15.07%

Financial Health Score

Excellent

BEATW maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
4.64

Profitability Score

Weak

BEATW struggles to sustain strong margins.

ROE > 15%
-402.72%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is BEATW Expensive or Cheap?

P/E Ratio

BEATW trades at -0.89 times earnings. This suggests potential undervaluation.

-0.89

PEG Ratio

When adjusting for growth, BEATW's PEG of -0.02 indicates potential undervaluation.

-0.02

Price to Book

The market values HeartBeam, Inc. at 3.29 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.29

EV/EBITDA

Enterprise value stands at -1.52 times EBITDA. This is generally considered low.

-1.52

How Well Does BEATW Make Money?

Net Profit Margin

For every $100 in sales, HeartBeam, Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-4.03 in profit for every $100 of shareholder equity.

-4.03%

ROA

HeartBeam, Inc. generates $-2.29 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.29%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.23 in free cash annually.

$-0.23

FCF Yield

BEATW converts -61.11% of its market value into free cash.

-61.11%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.89

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.29

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.64

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-4.03

vs 25 benchmark

ROA

Return on assets percentage

-2.29

vs 25 benchmark

ROCE

Return on capital employed

-2.85

vs 25 benchmark

How BEATW Stacks Against Its Sector Peers

MetricBEATW ValueSector AveragePerformance
P/E Ratio-0.8931.08 Better (Cheaper)
ROE-402.72%548.00% Weak
Net Margin0.00%-2521.00% (disorted) Weak
Debt/Equity0.000.11 Strong (Low Leverage)
Current Ratio4.645.78 Strong Liquidity
ROA-229.31%-228.00% (disorted) Weak

BEATW outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews HeartBeam, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-376.74%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-464.84%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ